Acceptance of COVID-19 Vaccination in India, after First Phase-Out: A Cross-Sectional Community-Based Study

N. Shukla, M. Agarwal, A. Khanna, A. C. Shukla, Anila Varghese
{"title":"Acceptance of COVID-19 Vaccination in India, after First Phase-Out: A Cross-Sectional Community-Based Study","authors":"N. Shukla, M. Agarwal, A. Khanna, A. C. Shukla, Anila Varghese","doi":"10.1055/s-0042-1743136","DOIUrl":null,"url":null,"abstract":"\n Background India rolled out the world's largest vaccination program on January 16, 2021, marking the beginning of an effort to vaccinate a population of 1.3 billion against coronavirus disease 2019 (COVID-19) infection. However, the hesitancy toward safe and effective vaccine against severe infection is a major global health threat. Hence, public acceptance of COVID-19 vaccine would be an essential deterrent to the pandemic control.\n Materials and Methods A cross-sectional online study was conducted among the Indians from January 1 to January 31, 2021. The online questionnaire addressed several variables, including the sociodemographic parameters, COVID-19 vaccine acceptance, and concerns regarding COVID-19 vaccine.\n Results Out of total 450 participants, majority of them (97.1) were aware about the COVID-19 vaccination drive. Only 66.2% showed their willingness to accept vaccination, 26.0% were still indecisive, and 7.8% did not want to accept it.\n Conclusion Despite numerous efforts by various scientific organizations, public health experts, and media outlets, to educate the general population about the COVID-19 vaccine, significant portion of the Indian population may experience vaccine hesitancy, which poses dangers to both the individual and their community. Therefore, we must target these potential candidates, who are indecisive, for intervention to increase vaccine acceptance across the country. In this regard, large-scale study is required to understand the knowledge, expectation, and apprehension covering various economic and occupational strata of the society.","PeriodicalId":53332,"journal":{"name":"Annals of the National Academy of Medical Sciences India","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the National Academy of Medical Sciences India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0042-1743136","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background India rolled out the world's largest vaccination program on January 16, 2021, marking the beginning of an effort to vaccinate a population of 1.3 billion against coronavirus disease 2019 (COVID-19) infection. However, the hesitancy toward safe and effective vaccine against severe infection is a major global health threat. Hence, public acceptance of COVID-19 vaccine would be an essential deterrent to the pandemic control. Materials and Methods A cross-sectional online study was conducted among the Indians from January 1 to January 31, 2021. The online questionnaire addressed several variables, including the sociodemographic parameters, COVID-19 vaccine acceptance, and concerns regarding COVID-19 vaccine. Results Out of total 450 participants, majority of them (97.1) were aware about the COVID-19 vaccination drive. Only 66.2% showed their willingness to accept vaccination, 26.0% were still indecisive, and 7.8% did not want to accept it. Conclusion Despite numerous efforts by various scientific organizations, public health experts, and media outlets, to educate the general population about the COVID-19 vaccine, significant portion of the Indian population may experience vaccine hesitancy, which poses dangers to both the individual and their community. Therefore, we must target these potential candidates, who are indecisive, for intervention to increase vaccine acceptance across the country. In this regard, large-scale study is required to understand the knowledge, expectation, and apprehension covering various economic and occupational strata of the society.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在首次淘汰后,印度接受COVID-19疫苗接种:一项基于社区的横断面研究
印度于2021年1月16日推出了世界上最大的疫苗接种计划,标志着为13亿人口接种2019年冠状病毒病(COVID-19)感染疫苗的努力开始。然而,对预防严重感染的安全有效疫苗的犹豫是一个主要的全球健康威胁。因此,公众对COVID-19疫苗的接受将是对大流行控制的重要威慑。材料与方法于2021年1月1日至1月31日对印度人进行横断面在线研究。在线问卷涉及多个变量,包括社会人口学参数、COVID-19疫苗接受度以及对COVID-19疫苗的担忧。结果在450名参与者中,大多数(97.1)人了解COVID-19疫苗接种活动。只有66.2%的人表示愿意接受疫苗接种,26.0%的人仍然犹豫不决,7.8%的人不想接受疫苗接种。尽管各种科学组织、公共卫生专家和媒体机构做出了大量努力,向公众宣传COVID-19疫苗,但很大一部分印度人口可能会出现疫苗犹豫,这对个人和社区都构成了危险。因此,我们必须针对这些犹豫不决的潜在候选者进行干预,以提高全国各地的疫苗接受度。在这方面,需要大规模的研究来了解涵盖社会各个经济和职业阶层的知识、期望和忧虑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
19
审稿时长
12 weeks
期刊最新文献
Glaucoma the Silent Thief of Vision! A Study to Assess Current Trends on Awareness and Knowledge About Glaucoma Molecular Genetic Analysis of Mycobacteria, Causing Female Genital Tuberculosis: Possibilities of Sexual Transmission—An Overview SARS-CoV-2 Genome Structure, Pathogenesis, Issues, and Challenges in Laboratory Diagnosis Cystatin A Down-regulation in Head and Neck Squamous Cell Carcinoma Cell Lines Decreases Cancer Hallmark Signatures Customized Elastics Fabricated from Foley's Catheter for Traction in Maxillofacial Trauma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1